Retour sur lavenir.net
   AB INBEV 69.640 € (+1,40 %)     RECTICEL 12.700 € (+1,44 %)     ACKERMANS V.HAAREN 263.400 € (-0,23 %)     NEXTENSA 45.600 € (-1,39 %)     KINEPOLIS GROUP 40.900 € (+0,62 %)     KBC ANCORA 91.900 € (+0,44 %)     WDP 21.300 € (-0,37 %)     GIMV 43.800 € (-0,34 %)     SOLVAY 26.200 € (-1,65 %)     LOTUS BAKERIES 12 680.000 € (+2,76 %)     AEDIFICA 68.000 € (-0,15 %)     SIPEF 99.000 € (+6,80 %)     KBC 130.300 € (+0,50 %)     TITAN S.A. 51.400 € (+0,78 %)     ARGENX SE 754.400 € (-0,87 %)     BREDERODE 102.800 € (-0,19 %)     CARE PROPERTY INV. 12.100 € (-0,49 %)     ONTEX GROUP 2.470 € (-1,00 %)     VAN DE VELDE 29.600 € (-0,34 %)     D'IETEREN GROUP 175.000 € (-0,91 %)     GBL 75.000 € (-0,99 %)     TUBIZE-FIN 183.700 € (-1,66 %)     CFE 11.800 € (-1,67 %)     MELEXIS 71.550 € (-1,31 %)     MATERIALISE 5.800 € (-2,52 %)     SYENSQO 80.200 € (-0,74 %)     DECEUNINCK 2.225 € (+0,23 %)     UMICORE 23.240 € (-4,05 %)     BARCO 7.910 € (-0,50 %)     TINC 11.200 € (-0,18 %)     BELYSSE GROUP 0.473 € (-1,46 %)     NYRSTAR 0.061 € (0,00 %)     ORANGE BELGIUM 22.000 € (0,00 %)     ELIA GROUP 132.000 € (+0,69 %)     BEKAERT 38.100 € (+0,66 %)     ECONOCOM GROUP 1.455 € (-2,35 %)     WERELDHAVE BELGIUM 52.400 € (-0,76 %)     INCLUSIO SA/NV 17.200 € (-1,15 %)     FAGRON 22.300 € (+0,45 %)     HOME INVEST BE. 19.240 € (-0,72 %)     VASTNED 29.050 € (0,00 %)     QUESTFOR GR-PRICAF 3.048 € (+1,60 %)     XIOR 27.250 € (-1,09 %)     UCB 219.100 € (-1,22 %)     JENSEN-GROUP 72.200 € (-0,82 %)     NYXOAH 1.384 € (-1,00 %)     VIOHALCO 17.660 € (-1,89 %)     SOFINA 248.200 € (-0,24 %)     BPOST 1.388 € (-0,72 %)     FLUXYS BELGIUM D 20.400 € (+1,49 %)     CENERGY 22.940 € (+2,78 %)     TESSENDERLO 20.850 € (-2,11 %)     PROXIMUS 6.240 € (-0,40 %)     MONTEA 66.000 € (-1,05 %)     COLRUYT 38.500 € (+0,68 %)     CAMPINE 203.000 € (+0,50 %)     CMB.TECH 14.720 € (+2,22 %)     AGEAS 72.350 € (-0,55 %)     ENERGYVISION 15.220 € (-1,68 %)     EVS 28.350 € (+1,43 %)  
   CVC CAPITAL 15.290 € (+0,46 %)     HAFFNER ENERGY 0.620 € (-10,66 %)     VINCI 121.950 € (-1,09 %)     AHOLD DEL 32.460 € (+1,85 %)     EXAIL TECHNOLOGIES 124.500 € (-0,24 %)     CARREFOUR 15.725 € (-0,19 %)     PROSUS 38.100 € (-1,45 %)     UNILEVER 54.170 € (+0,99 %)     SAFRAN 358.000 € (-1,54 %)     ASML HOLDING 1 609.400 € (+2,71 %)     BANIJAY GROUP 10.100 € (+10,02 %)     BE SEMICONDUCTOR 235.200 € (+1,47 %)     MEDIANTECHNOLOGIES 4.710 € (+1,84 %)     CSG 18.888 € (+2,37 %)     ASM INTERNATIONAL 907.800 € (+1,11 %)     ING GROEP N.V. 30.820 € (-0,26 %)     Vusion 133.300 € (+0,98 %)     ALTHEORA 0.386 € (-5,85 %)     FASTNED 35.800 € (+9,15 %)     AMG 33.660 € (-0,53 %)     COFACE 15.920 € (-0,62 %)     HAL TRUST 165.000 € (0,00 %)     THALES 268.600 € (-1,21 %)     BIOSYNEX 1.000 € (0,00 %)     SCHNEIDER ELECTRIC 309.250 € (-0,56 %)     ADYEN 1 059.200 € (+16,40 %)     ARCELORMITTAL SA 63.660 € (-0,81 %)     NEXANS 142.500 € (-1,52 %)     S.E.B. 59.600 € (+1,62 %)     LVMH 460.000 € (-1,06 %)     TRIODOS BANK 34.700 € (+9,46 %)     SPINEGUARD 0.087 € (-0,57 %)     VOPAK 47.160 € (+0,26 %)     AKWEL 6.700 € (-0,89 %)     SEMCO TECHNOLOGIES 45.000 € (-0,66 %)     SCOR SE 34.080 € (-0,53 %)     EIFFAGE 121.250 € (-0,70 %)     GECINA 74.050 € (-0,07 %)     ABN AMRO BANK N.V. 41.500 € (-0,69 %)     NANOBIOTIX 33.180 € (-3,88 %)     LOUIS HACHETTE 1.870 € (+0,48 %)     SHELL PLC 38.605 € (-0,25 %)     HAVAS 18.700 € (-2,09 %)     CORBION 19.750 € (+0,30 %)     SOCIETE GENERALE 82.870 € (-0,30 %)     MAGNUM 17.340 € (+2,11 %)     BIOPHYTIS 0.057 € (+51,47 %)     AEGON 8.150 € (-0,61 %)     UMG 14.650 € (-1,55 %)     ACCOR 46.560 € (+0,47 %)     PHILIPS KON 23.690 € (+2,16 %)     CRCAM LANGUED CCI 91.000 € (0,00 %)     KAUFMAN ET BROAD 24.950 € (-0,20 %)     HEXAOM 29.000 € (+3,20 %)     CARMILA 16.580 € (-0,60 %)     WOLTERS KLUWER 68.320 € (-1,21 %)     CROSSJECT 1.434 € (-2,32 %)     PHARMING GROUP 1.028 € (+2,39 %)     LAKEFRONT BIOTHER. 24.300 € (-0,57 %)     ALTAREA 98.800 € (-0,30 %)  
News Réglementées
13/08/2026 14:15

Aspire Biopharma Holdings, Inc., to Present at Sidoti Virtual Investor Conference August 19th

ESTERO, FL / ACCESS Newswire / August 13, 2026 / Aspire Biopharma Holdings, Inc. (Nasdaq:ASBP) ("Aspire" or the "Company"), today announced that management will be present and host one-on-one meetings with investors at Sidoti & Company's Micro-Cap Virtual Investor Conference taking place on August 19-20, 2026.

Management plans to discuss its clinical and commercial development pipeline and its recently closed acquisition of Dura Driver Control Systems, a leading global automotive supplier with a 100+ year history and $200M+ in 2025 revenue.

Sidoti Micro-Cap Virtual Conference Presentation Details
Dates: August 19-20, 2026
Date and Time: Wednesday, August 19, 2026, at 1:45 P.M. ET
Webcast: https://sidoti.zoom.us/webinar/register/WN_udxBu7lMQ9iYsAS6ydaFVA

One-on-One Meetings

Inspire will also host virtual one-on-ones with investors on Wednesday, August 19 and Thursday, August 20, 2026. To register for the presentation or one-on ones, visit https://sidoti.com/events.

About Aspire Biopharma Holdings, Inc.

Aspire Biopharma has developed a patent-pending sublingual delivery technology that can deliver drugs to the body rapidly and precisely. This technology offers the potential to improve effectiveness and reduce side effects by going directly to the bloodstream and avoiding the gastrointestinal tract. Aspire Biopharma's delivery technology can be applied to many different active pharmaceutical ingredients (APIs) and other bioactive substances.

Aspire's subsidiary Dura Driver Control Systems is a leading designer and manufacturer of highly engineered automotive and industrial systems that facilitate electronic driver control and support migration toward vehicle electrification, safety, lightweighting, and sustainability. DCS maintains a strong powertrain agnostic product portfolio that includes mechatronic actuators, human machine interfaces, industrial cables, and cable control systems backed by over 310 patents. The Company operates 11 manufacturing facilities globally and serves as a tier one automotive supplier to major OEMs and other industrial firms.

For more information, please visit www.aspirebiolabs.com

Aspire Biopharma Holdings, Inc.

Contact:

PCG Advisory
Kevin McGrath
+1-646-418-7002
kevin@pcgadvisory.com

SOURCE: Aspire Biopharma Holdings, Inc.



View the original press release on ACCESS Newswire

Source : Webdisclosure.com

© 2026 Tous droits réservés
Cotations différées d'au moins 15 minutes (Paris, Amsterdam, Bruxelles, Lisbonne).
Cotations à la clôture (Francfort, New-York, Londres, Zurich).
Flux de cotations : Euronext (Places Euronext et Cours des Devises).
Bourse : technologie Cote Boursière